Supplementary materials for A Phase III Study to Compare Efficacy and Safety of BAT2206 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/w2vksw3xdd
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary tables
提供机构：
Zhejiang University
